Denali Therapeutics Inc. (DNLI)
Market Closed
26 Oct, 08:00 PM
$
18. 66
+0.25
+1.358%
$
2.94B Market Cap
- P/E Ratio
- Div Yield
679,457 Volume
-1.08 Eps
$ 18.41
Previous Close 
Want to track DNLI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
3 Longevity Stocks to Buy for Anti-Aging Breakthroughs
The United States population is aging faster than ever, attracting interest in longevity stocks. By 2030, one in five Americans will be a senior citizen, up from one in twenty 100 years ago.
Investorplace | 2 years ago
Denali (DNLI) Outperforms Industry in 3 Months: Here's Why
Denali (DNLI) gains 11.9% in three months on positive updates on its candidates.
Zacks | 2 years ago
Denali Therapeutics (DNLI) Moves 5.8% Higher: Will This Strength Last?
Denali Therapeutics (DNLI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks | 2 years ago
Why Is Denali Therapeutics (DNLI) Up 15.6% Since Last Earnings Report?
Denali Therapeutics (DNLI) reported earnings 30 days ago. What's next for the stock?
Zacks | 2 years ago
Denali's (DNLI) Candidate Selected for FDA's START Pilot Program
Denali's (DNLI) DNL126, an investigational enzyme replacement therapy, gets selected for the START Pilot Program, intended to accelerate the development of rare disease therapies.
Zacks | 2 years ago
2026 © Marketlog. All Rights Reserved.
